Axogen, Inc. — Director's Dealing 2025

Dec 10, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2025-12-09

Reporting Person: TYNDALL JOSEPH A. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-12-09	Common Stock	M	14248	$7.04	Acquired	14248	Direct
2025-12-09	Common Stock	M	10860	$10.95	Acquired	25108	Direct
2025-12-09	Common Stock	S	14248	$30.977	Disposed	10860	Direct
2025-12-09	Common Stock	S	10860	$30.977	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-12-09	Employee Stock Option (right to purchase)	$7.04	M	14248	Disposed	2034-06-06	Common Stock (14248)	Direct
2025-12-09	Stock Option (right to purchase)	$10.95	M	10860	Disposed	2032-12-13	Common Stock (10860)	Direct

Footnotes

F1: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $30.485 to $31.305 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2: Non-qualified stock option portion of the 2024 annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The grant vested on June 6, 2025, the one-year anniversary of the grant date.

F3: Option grant for joining the Issuer's Board of Directors. Options vest in three equal annual installments on the annual anniversary of the grant date with the first vesting date occurring on December 13, 2023.